Clostridium difficile
Asymptomatic C. Difficile Carriers Prone to Progress to Infection in the Hospital
A longitudinal study of ICU patients found that transition from asymptomatic C. difficile carriage to full-blown infection was far more common than transmission between patients.
Day Zero Diagnostics Wins $300K SBIR Grant for Fecal Microbiota Transplant Assay
The Boston firm will develop a sequencing-based safety and efficacy assay for fecal microbiota transplants called epiXact FMT.
Microbes Behind Successful Fecal Microbiota Transplantations May Become Basis for New Treatments
With microbial sequencing data for FMT donors and recipients, researchers defined which bugs take up long-term residence in recipient guts.
Diagenode already sells more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses for multiple infectious diseases.
C. Difficile Epigenomic Analysis Uncovers Highly Conserved Methyltransferase
A group led by Mount Sinai researchers said this methyltransferase, which is involved in sporulation, could be targeted to fight infections.
May 14, 2019
Mobidiag Secures €25M Loan to Build Test Menu
May 2, 2019
Nov 28, 2018
Nov 15, 2018
Nov 8, 2018
Meridian Bioscience Q4 Revenues Grow 7 Percent
Oct 23, 2018
GenePOC C. Diff MDx Approved in Canada
Jul 31, 2018
Meridian Bioscience Q3 Revenues Grow 3 Percent
Apr 9, 2018
Jan 12, 2018
JPM Healthcare Day Four: Natera and Luminex
Nov 28, 2017
GenePOC C. Diff Test Receives FDA Approval
Nov 27, 2017